Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis

BACKGROUND: For patients with MS, medication switches increase the risk of disease reactivation. OBJECTIVE: Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Norborg, Hilde, Riise, Trond, Myhr, Kjell-Morten, Grytten, Nina, Wergeland, Stig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209840/
https://www.ncbi.nlm.nih.gov/pubmed/34188949
http://dx.doi.org/10.1177/20552173211022027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209840/
https://www.ncbi.nlm.nih.gov/pubmed/34188949
http://dx.doi.org/10.1177/20552173211022027

Ejemplares similares